A detailed history of Davenport & CO LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Davenport & CO LLC holds 75,598 shares of IONS stock, worth $2.57 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
75,598
Previous 80,678 6.3%
Holding current value
$2.57 Million
Previous $3.85 Million 21.25%
% of portfolio
0.02%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$40.06 - $51.86 $203,504 - $263,448
-5,080 Reduced 6.3%
75,598 $3.03 Million
Q2 2024

Aug 06, 2024

SELL
$36.45 - $47.7 $118,462 - $155,025
-3,250 Reduced 3.87%
80,678 $3.85 Million
Q1 2024

May 03, 2024

SELL
$42.03 - $53.55 $100,872 - $128,520
-2,400 Reduced 2.78%
83,928 $3.64 Million
Q4 2023

Jan 23, 2024

SELL
$43.39 - $51.63 $23,821 - $28,344
-549 Reduced 0.63%
86,328 $4.37 Million
Q3 2023

Oct 17, 2023

SELL
$38.5 - $47.13 $36,190 - $44,302
-940 Reduced 1.07%
86,877 $3.94 Million
Q2 2023

Jul 20, 2023

BUY
$34.73 - $43.33 $250,055 - $311,976
7,200 Added 8.93%
87,817 $3.6 Million
Q4 2022

Jan 20, 2023

SELL
$37.12 - $46.52 $157,611 - $197,523
-4,246 Reduced 5.0%
80,617 $0
Q3 2022

Oct 11, 2022

BUY
$36.54 - $48.66 $56,454 - $75,179
1,545 Added 1.85%
84,863 $3.75 Million
Q2 2022

Jul 18, 2022

SELL
$31.71 - $43.0 $17,281 - $23,435
-545 Reduced 0.65%
83,318 $3.08 Million
Q1 2022

May 02, 2022

SELL
$29.88 - $37.04 $23,904 - $29,632
-800 Reduced 0.94%
83,863 $3.11 Million
Q4 2021

Feb 10, 2022

SELL
$25.61 - $35.1 $963,960 - $1.32 Million
-37,640 Reduced 30.78%
84,663 $2.58 Million
Q3 2021

Oct 14, 2021

BUY
$33.54 - $40.55 $179,103 - $216,536
5,340 Added 4.57%
122,303 $4.1 Million
Q2 2021

Jul 28, 2021

SELL
$34.54 - $47.25 $268,548 - $367,368
-7,775 Reduced 6.23%
116,963 $4.66 Million
Q1 2021

Apr 28, 2021

BUY
$42.51 - $63.78 $110,526 - $165,828
2,600 Added 2.13%
124,738 $5.61 Million
Q4 2020

Jan 13, 2021

SELL
$45.3 - $60.27 $18,120 - $24,108
-400 Reduced 0.33%
122,138 $6.91 Million
Q3 2020

Oct 15, 2020

SELL
$47.45 - $62.95 $191,603 - $254,192
-4,038 Reduced 3.19%
122,538 $5.81 Million
Q2 2020

Jul 28, 2020

SELL
$46.85 - $61.05 $480,212 - $625,762
-10,250 Reduced 7.49%
126,576 $7.46 Million
Q1 2020

May 05, 2020

SELL
$41.6 - $63.4 $3.29 Million - $5.01 Million
-79,086 Reduced 36.63%
136,826 $6.47 Million
Q4 2019

Jan 22, 2020

BUY
$53.85 - $65.27 $3.76 Million - $4.55 Million
69,746 Added 47.72%
215,912 $13 Million
Q2 2019

Jul 10, 2019

SELL
$62.09 - $86.14 $1.78 Million - $2.47 Million
-28,636 Reduced 16.38%
146,166 $9.39 Million
Q1 2019

Apr 17, 2019

SELL
$52.92 - $81.17 $2.71 Million - $4.15 Million
-51,165 Reduced 22.64%
174,802 $14.2 Million
Q4 2018

Jan 28, 2019

BUY
$43.37 - $59.54 $477,416 - $655,416
11,008 Added 5.12%
225,967 $12.2 Million
Q3 2018

Oct 11, 2018

BUY
$42.88 - $53.7 $1.46 Million - $1.83 Million
34,022 Added 18.8%
214,959 $11.1 Million
Q2 2018

Jul 09, 2018

BUY
$40.53 - $50.7 $3.33 Million - $4.17 Million
82,247 Added 83.34%
180,937 $7.54 Million
Q1 2018

Apr 04, 2018

BUY
$44.08 - $55.05 $1.61 Million - $2.01 Million
36,545 Added 58.81%
98,690 $4.35 Billion
Q4 2017

Jan 17, 2018

BUY
$50.3 - $64.39 $1.47 Million - $1.88 Million
29,245 Added 88.89%
62,145 $3.13 Billion
Q3 2017

Oct 12, 2017

BUY
$45.56 - $59.57 $1.5 Million - $1.96 Million
32,900
32,900 $1.67 Billion

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.83B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Davenport & CO LLC Portfolio

Follow Davenport & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.